Cervical spondylotic myelopathy (CSM) is a degenerative condition that results in a non-traumatic, progressive and chronic compression of the cervical spinal cord. Surgery is indicated for patients with moderate to severe myelopathy or progressive myelopathy. Literature shows that decompressive surgery halts progression of the condition. We undertook this study to see if there is a worthwhile improvement in function in patients who had spine decompression for cervical spondylotic myelopathy. From a retrospective review of our medical records, a total of 61 patients had decompressive surgery for cervical myelopathy during the period between January 2008 and January 2014. 11 Patients were excluded because their cervical myelopathy was due to compression from tuberculosis or a tumour. 33 patients had incomplete records. We are reporting on the 17 patients who had complete records. From the patients' notes we recorded the detailed preoperative neurologic examination usually done for these patients in our clinic. This was compared to the neurological examination done at 6 months, 12 months and at more than 2 years follow-up. Where this examination was not adequate, patients were called in for the neurologic examination.Introduction:
Material and Method:
The purpose of this study was to establish the diagnostic utility and spectrum of fluoroscopy guided percutaneous transpedicular biopsies of the thoraco-lumbar spine performed at our institution and to review some aspects regarding the diagnosis of spinal tuberculosis (TB). A retrospective study was performed on a consecutive series of 48 patients who underwent fluoroscopy guided percutaneous transpedicular biopsies of the spine performed at our institution. Biopsy specimens were sent for microscopy, culture and sensitivity (MC&S) as well as for TB microscopy, culture and polymerase chain reaction (PCR) and for histology.Aim
Methods
Positron emission tomography (PET) is a technology widely used in oncology. It is now being increasingly used in orthopaedics, especially in diagnosing bone infection. Diagnosis of bone infection is still a challenge, especially after surgery. Bone scintigraphy, Gallium-67 scintigraphy, and radiolabelled leucocyte scintigraphy are not specific. MRI has problems with definition in the presence of metal. PET uses 18-F Fluoro deoxyglucose(FDG) as a radiotracer. Inflammatory cells use glucose for energy, and the 18F-Fluoride component of FDG is a positron-emitting radionucleotide. We undertook this study to show our experience with the FDG-PET –CT in diagnosing bone infection and to highlight its superiority in diagnosing infected spine implants. Medical records of orthopaedic patients referred to the nuclear medicine department in our hospital were retrospective reviewed. We looked at the clinical records, radiographs, bone scintigraphs, MRI and FDG-PET, assessing their diagnostic accuracy, and their value in helping the surgeon plan treatment.Background and objectives
Material and Methods
